8 unchanged sentences
Based on this evaluation, management concluded that our internal control over financial reporting was effective as of December 31, 2025.
−Removed: We excluded Chemspeed Technologies AG, Dynamic Biosensors GmbH, ELITechGroup, Nanophoton Corporation, NanoString Technologies, Nion LLC, Phasefocus Holdings Limited, Spectral Instruments Imaging LLC, and Tornado Spectral Systems Inc., from our assessment of internal control over financial reporting as of December 31, 2024, because they were acquired by the Company in business combinations during 2024.
−Removed: The total assets and total revenues of the acquired entities collectively represent approximately 7% and 7%, respectively, of the related consolidated financial statement amounts as of and for the year ended December 31, 2024.
+Added: We excluded Biocrates Life Sciences GmbH, Ridom GmbH, RECIPE Chemicals + Instruments GmbH, and Molzym GmbH &Co.
+Added: KG from our assessment of internal control over financial reporting as of December 31, 2025, because they were acquired by the Company in business combinations during 2025.
+Added: The total assets and total revenues of the acquired entities collectively represent less than 1% and 1%, respectively, of the related consolidated financial statement amounts as of and for the year ended December 31, 2025.
The effectiveness of our internal control over financial reporting as of December 31, 2025, has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report, which appears in this Annual Report on Form 10-K.
2 unchanged sentences
ITEM 9B OTHER INFORMATION
−Removed: On November 25, 2024 , Dr.
−Removed: Cynthia Friend , a member of the Company’s Board of Directors , terminated a trading plan she had previously adopted with respect to the sale of securities of the Company’s common stock, intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act (“Rule 10b5-1 Trading Plan”).
−Removed: Friend’s Rule 10b5-1 Trading Plan was adopted on March 11, 2024 , and provided for the sale of up to 1,785 shares of the Company’s common stock through December 31, 2024 .
−Removed: As of the date of termination of her Rule 10b5-1 Trading Plan, Dr.
−Removed: Friend did not sell any shares of common stock under the terms of the Rule 10b5-1 Trading Plan.
−Removed: Other than as disclosed above, none of our directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted , modified or terminated any contract, instruction, or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act or any non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K) during the three months ended December 31, 2024 .
+Added: During the quarter ended December 31, 2025, none of our directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted , modified or terminated any contract, instruction, or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act or any non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K) during the three months ended December 31, 2025.
ITEM 9C DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS
3 unchanged sentences
We intend to disclose future amendments to certain provisions of our Code, or waivers of such provisions granted to executive officers and directors, on the website within four business days following the date of such amendment or waiver.
+Added: We have adopted an Insider Trading Policy that applies to our employees, officers, and directors.
+Added: We believe that the Insider Trading Policy is reasonably designed to promote compliance with insider trading laws, rules, and regulations with respect to the purchase, sale, and/or other dispositions of our securities, as well as the applicable rules and regulations of Nasdaq.
+Added: A copy of our Insider Trading Policy is filed as Exhibit 19.1 to this Annual Report.
The information required by this item of Form 10-K is incorporated by reference to our definitive proxy statement (which will be filed with the SEC pursuant to Regulation 14A under the Exchange Act) relating to our 2026 Annual Meeting of Shareholders.
20 unchanged sentences
Amended and Restated Bylaws of Bruker Corporation
+Added: Certificate of Designations of 6.375% Mandatory Convertible Preferred Stock, Series A of Bruker Corporation.
+Added: September 8, 2025
Specimen Stock Certificate Representing Shares of Common Stock of Bruker Corporation
23 unchanged sentences
January 19, 2012
−Removed: First Amendment to the Note Purchase Agreement, date January 18, 2012
+Added: First Amendment to the Note Purchase Agreement, dated January 18, 2012
August 7, 2020
2 unchanged sentences
Bruker Corporation 2022 Short-Term Incentive Compensation Program
+Added: February 28, 2022
Offer Letter, dated June 4, 2018, by and between the Company and Gerald N.
52 unchanged sentences
Morgan Securities LLC.
+Added: Bruker Corporation 2026 Incentive Compensation Plan
Insider Trading Policy of Bruker Corporation.
7 unchanged sentences
Bruker Corporation Compensation Recoupment Policy
−Removed: Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document
−Removed: Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents
−Removed: Inline XBRL Taxonomy Extension Calculation Linkbase Document
−Removed: Inline XBRL Taxonomy Extension Definition Linkbase Document
−Removed: Inline XBRL Taxonomy Extension Label Linkbase Document
−Removed: Inline XBRL Taxonomy Extension Presentation Linkbase Document
−Removed: Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
+Added: Inline XBRL Instance Document — the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the inline XBRL document
+Added: Inline XBRL Taxonomy Extension Schema Document with Embedded Linkbase Documents
+Added: Cover page formatted in Inline XBRL and contained in Exhibit 101
* Certain portions have been omitted pursuant to an order granting confidential treatment and have been filed separately with the Securities and Exchange Commission.
7 unchanged sentences
BRUKER CORPORATION
−Removed: March 3, 2025
+Added: February 27, 2026
LAUKIEN, PH.D.
8 unchanged sentences
(Principal Executive Officer)
−Removed: March 3, 2025
+Added: February 27, 2026
Laukien, Ph.D.
2 unchanged sentences
(Principal Financial Officer)
−Removed: March 3, 2025
−Removed: /S/ THOMAS BURES
+Added: February 27, 2026
+Added: /S/ THOMAS M.
Chief Accounting Officer
(Principal Accounting Officer)
−Removed: March 3, 2025
+Added: February 27, 2026
/S/ BONNIE H.
−Removed: March 3, 2025
+Added: February 27, 2026
/S/ CYNTHIA M.
FRIEND, PH.D.
−Removed: March 3, 2025
−Removed: Cynthia Friend, Ph.D.
+Added: February 27, 2026
+Added: Friend, Ph.D.
/S/ WILLIAM A.
−Removed: March 3, 2025
−Removed: /S/ JOHN ORNELL
−Removed: March 3, 2025
+Added: February 27, 2026
+Added: February 27, 2026
/S/ RICHARD A.
−Removed: March 3, 2025
+Added: February 27, 2026
/S/ ADELENE Q.
−Removed: March 3, 2025
−Removed: /S/ HERMANN REQUARDT, PH.D.
−Removed: March 3, 2025
−Removed: Hermann Requardt, Ph.D.
−Removed: /S/ ROBERT ROSENTHAL, PH.D.
−Removed: March 3, 2025
−Removed: Robert Rosenthal, Ph.D.
−Removed: /S/ LAURA FRANCIS
−Removed: March 3, 2025
−Removed: Laura Francis
+Added: February 27, 2026
+Added: /S/ HERMANN F.
+Added: REQUARDT, PH.D.
+Added: February 27, 2026
+Added: Requardt, Ph.D.
+Added: /S/ ROBERT J.
+Added: ROSENTHAL, PH.D.
+Added: February 27, 2026
+Added: Rosenthal, Ph.D.
+Added: February 27, 2026
+Added: (JACK) PHILLIPS
+Added: February 27, 2026
+Added: (Jack) Phillips
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.